BIGBEAR
PHARMACEUTICALS
Larotrectinib is the world’s first highly selective neurotrophic tyrosine receptor kinase (TRK) inhibitor and a tissue-agnostic precision targeted antineoplastic agent.
AuthenticGuaranteeFast DeliveryPrivacy Classification of LarotrectinibLarotrectinib is a targeted therapeutic agent belonging to the class of TRK inhibitors.It acts by selectively inhibitin···【Read More】
Update: 11 Mar,2026Source: Haiou HealthViews: 72
Copyright2024@ BIGBEAR All right reserved BIGBEAR
